BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24136019)

  • 21. British OsteoNEcrosis Study (BONES) protocol: a prospective cohort study to examine the natural history of osteonecrosis in older children, teenagers and young adults with acute lymphoblastic leukaemia and lymphoblastic lymphoma.
    Amin N; Kinsey S; Feltbower R; Kraft J; Whitehead E; Velangi M; James B
    BMJ Open; 2019 May; 9(5):e027204. PubMed ID: 31122988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical impact of corticosteroid-induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low-dose adrenocorticotropin test.
    Rix M; Birkebaek NH; Rosthøj S; Clausen N
    J Pediatr; 2005 Nov; 147(5):645-50. PubMed ID: 16291357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patients.
    Gagné V; Aubry-Morin A; Plesa M; Abaji R; Petrykey K; St-Onge P; Beaulieu P; Laverdière C; Alos N; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
    Pharmacogenomics; 2019 Nov; 20(17):1189-1197. PubMed ID: 31686588
    [No Abstract]   [Full Text] [Related]  

  • 24. Osteonecrosis during the treatment of childhood acute lymphoblastic leukemia: a prospective MRI study.
    Ojala AE; Pääkkö E; Lanning FP; Lanning M
    Med Pediatr Oncol; 1999 Jan; 32(1):11-7. PubMed ID: 9917747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis.
    Patel B; Richards SM; Rowe JM; Goldstone AH; Fielding AK
    Leukemia; 2008 Feb; 22(2):308-12. PubMed ID: 17989709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maintenance therapy and risk of osteonecrosis in children and young adults with acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study.
    Toksvang LN; Andrés-Jensen L; Rank CU; Niinimäki R; Nersting J; Nielsen SN; Mogensen SS; Harila-Saari A; Abrahamsson J; Joelsson J; Overgaard UM; Quist-Paulsen P; Griškevičius L; Jónsson ÓG; Vaitkevičienė G; Frandsen TL; Toft N; Grell K; Schmiegelow K
    Cancer Chemother Pharmacol; 2021 Nov; 88(5):911-917. PubMed ID: 34145469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired adrenal function after glucocorticoid therapy in children with acute lymphoblastic leukemia.
    Petersen KB; Müller J; Rasmussen M; Schmiegelow K
    Med Pediatr Oncol; 2003 Aug; 41(2):110-4. PubMed ID: 12825213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
    Welte K; Reiter A; Mempel K; Pfetsch M; Schwab G; Schrappe M; Riehm H
    Blood; 1996 Apr; 87(8):3143-50. PubMed ID: 8605328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia.
    te Winkel ML; Appel IM; Pieters R; van den Heuvel-Eibrink MM
    Haematologica; 2008 Oct; 93(10):1570-4. PubMed ID: 18698082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steroids and risk of osteonecrosis in ALL: take a break.
    van den Heuvel-Eibrink MM; Pieters R
    Lancet Oncol; 2012 Sep; 13(9):855-7. PubMed ID: 22901621
    [No Abstract]   [Full Text] [Related]  

  • 31. Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL).
    Padhye B; Dalla-Pozza L; Little D; Munns C
    Cancer Med; 2016 May; 5(5):960-7. PubMed ID: 26792372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.
    Vrooman LM; Stevenson KE; Supko JG; O'Brien J; Dahlberg SE; Asselin BL; Athale UH; Clavell LA; Kelly KM; Kutok JL; Laverdière C; Lipshultz SE; Michon B; Schorin M; Relling MV; Cohen HJ; Neuberg DS; Sallan SE; Silverman LB
    J Clin Oncol; 2013 Mar; 31(9):1202-10. PubMed ID: 23358966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low Incidence of Osteonecrosis in Childhood Acute Lymphoblastic Leukemia Treated With ALL-97 and ALL-02 Study of Japan Association of Childhood Leukemia Study Group.
    Sakamoto K; Imamura T; Kihira K; Suzuki K; Ishida H; Morita H; Kanno M; Mori T; Hiramatsu H; Matsubara K; Terui K; Takahashi Y; Suenobu SI; Hasegawa D; Kosaka Y; Kato K; Moriya-Saito A; Sato A; Kawasaki H; Yumura-Yagi K; Hara J; Hori H; Horibe K
    J Clin Oncol; 2018 Mar; 36(9):900-907. PubMed ID: 29360413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On a case of multifocal osteonecrosis in a patient suffering from acute lymphoblastic leukemia.
    Solarino G; Scialpi L; Bruno M; De Cillis B
    Chir Organi Mov; 2008 Sep; 92(2):119-22. PubMed ID: 18473129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL).
    Kotecha RS; Powers N; Lee SJ; Murray KJ; Carter T; Cole C
    Pediatr Blood Cancer; 2010 Jul; 54(7):934-40. PubMed ID: 20127847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A
    Zgheib NK; El-Khoury H; Maamari D; Basbous M; Saab R; Muwakkit SA
    Per Med; 2021 Sep; 18(5):431-439. PubMed ID: 34406079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence, risk factors, and treatment outcome of symptomatic osteonecrosis in Taiwanese children with acute lymphoblastic leukemia: a retrospective cohort study of 245 patients in a single institution.
    Chen SH; Chang TY; Jaing TH; Lee MS; Wang CJ; Hung IJ; Yang CP
    Int J Hematol; 2015 Jul; 102(1):41-7. PubMed ID: 25840770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group.
    Labar B; Suciu S; Willemze R; Muus P; Marie JP; Fillet G; Berneman Z; Jaksic B; Feremans W; Bron D; Sinnige H; Mistrik M; Vreugdenhil G; De Bock R; Nemet D; Gilotay C; Amadori S; de Witte T;
    Haematologica; 2010 Sep; 95(9):1489-95. PubMed ID: 20378563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of osteonecrosis and improved survival in B-ALL: results of Children's Oncology Group Trial AALL0232.
    Mattano LA; Devidas M; Loh ML; Raetz EA; Chen Z; Winick NJ; Hunger SP; Carroll WL; Larsen EC
    Leukemia; 2024 Feb; 38(2):258-265. PubMed ID: 38062123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.